Clinical Trials Browser

Phase 3 × OTHER × Diet Therapy × Clear all

NCT06954584 2025-06-24

Fluzoparib+Bevacizumab/Dietary Intervention vs Fluzoparib Monotherapy as First-line Maintenance in HRD+/- Advanced Ovarian Cancer

Phase 3 Recruiting

Ovarian Neoplasms

NCT01482286 2022-03-15

PULSE

Phase 3 Terminated

32 enrolled 10 charts

Body Weight, Insulin Resistance, Motor Activity, Polycystic Ovary Syndrome